Report #2856646

Received Sep 3, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: Age unknown
State: NC
Recovered: Unknown
Vaccinated: Aug 22, 2025
Onset: Aug 22, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
RSV	RSV (AREXVY)	GLAXOSMITHKLINE BIOLOGICALS	UNK	42B52	IM

Symptoms (1)

Expired product administered

Symptom narrative

expired dose of Arexvy was administered; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 75-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) (batch number 42B52, expiry date 06-JUL-2025) for prophylaxis. On 22-AUG-2025, the patient received Arexvy (intramuscular). On 22-AUG-2025, an unknown time after receiving Arexvy, the patient experienced expired vaccine used (Verbatim: expired dose of Arexvy was administered). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 22-AUG-2025 The Pharmacist called to report an expired dose of Arexvy was administered to a 75-year-old patient, which led to expired vaccine used.